SYNTERA BIORISK
SpeciesCattleReleaseItaly · 2026-09-07
  1. Global Overview
  2. Europe
  3. Italy
  4. Lumpy skin disease
Country–disease dossierItaly · Lumpy skin disease
View economic evidence Run scenarioCompare interventionsInspect BCR assumptions Vaccine & intervention marketTrade analysis
Italy cross-disease portfolio ITALY DISEASE PROFILE · LINKED WORKSPACE

Lumpy skin disease

Official evidence, 21-region exposure and transparent national planning economics.

Profile readyEvidence + editable CBA
African swine feverregionalised eu control zonesHighly pathogenic avian influenzanotifiable seasonal surveillanceBluetongueofficial vector season surveillanceBovine tuberculosisterritorial status and surveillanceFoot-and-mouth diseaseofficial status and category a preparednessPeste des petits ruminantsofficial status and category a preparednessNewcastle diseasenotifiable poultry disease surveillanceClassical swine feverofficial status and category a preparednessSheep pox and goat poxcategory a external incursion preparednessLumpy skin diseasecategory a external incursion preparednessBovine viral diarrhoeaterritorial status or control programmeJohne’s diseasenational control context no current prevalenceEpizootic haemorrhagic diseasenotifiable vector incursion preparedness
Official disease status · 2026-09-07

Lumpy skin disease

No current domestic event count is asserted; official notification and Category A controls define preparedness.

Selected geography
Italy
Susceptible livestock
6m
Evidence nature
Observed / official
Exposure layer

Italy · susceptible livestock

Eurostat GISCO NUTS 2021
Exposure is livestock inventory—not inferred prevalence. Regional selection updates supported evidence; the CBA remains explicitly national because regional cost evidence is unavailable.
Validated exposure

Italy

cattle6m

Eurostat ef_lsk_main · 2020 observations; source grain retained.

Official signal at selected grain

No numeric national event series is published in the registered official source. The status narrative remains available.

Observed economics · national/source scope
Observed direct loss · national
N/A
Published programme cost · source scope
N/A
Monetised trade effect
N/A

No compatible current Italy-specific direct-loss estimate is registered; no value is inferred.

Relevant wildlife & interface

Wildlife evidence

No compatible current national wildlife-population layer is registered.

Population denominators remain unavailable unless explicitly registered; qualitative host evidence is not converted into a count.
ILLUSTRATIVE

Illustrative scenario—country-specific intervention evidence unavailable.

The planning parameters are retained, but the BCR is not estimated in this public profile.

Open Impact CalculatorWhy these assumptions?
Control choices

Default option scenarios

  1. 01Transport hygienePlanning option retained for explicit activation in Scenario Lab
  2. 02Vector controlPlanning option retained for explicit activation in Scenario Lab
  3. 03Emergency vaccination readinessPlanning option retained for explicit activation in Scenario Lab
Trade & movement

Documented consequence

Transport hygiene, vector control, notification and emergency vaccination readiness.

Registered sources document controls but not a compatible Italy-wide monetised trade consequence.
Release principle: every Italy disease has a complete decision workspace. Missing observed economics stay visible as N/A; modelled planning values are separately labelled, editable and never presented as evidence.
Sustainability & One HealthCountry-specific GHG, AMU/AMR and biodiversity results remain withheld until compatible evidence is registered; none is inferred from the disease profile.
Request complete Decision Brief